This was the stock's fourth consecutive day of gains.

This was the stock's third consecutive day of gains.

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies developed based on information obtained by reverse ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...

Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...

Check Out Our Latest Stock Report on Bio-Techne Bio-Techne Stock Performance Shares of TECH opened at $73.79 on Friday. The company has a 50-day simple moving average of $73.72 and a two-hundred ...

Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given ...

Several retail projects are planned in 2025 for Washington Avenue near the entrance of the Amazon warehouse, including a ...

A simple prototype cell sorter has grown over time to incorporate technological advances that make it an even more indispensable tool for understanding biology and disease states ...

Development projects in Meriden, Wallingford, Southington and Cheshire are set to transform the region in 2025.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...